Evidence map›Paper›PMID 19209406›Full record

ArticleJournal of neurochemistry2009

Statins decrease dendritic arborization in rat sympathetic neurons by blocking RhoA activation.

Woo-Yang Kim, Eugene A Gonsiorek, Chris Barnhart, Monika A Davare, Abby J Engebose, Holly Lauridsen, Donald Bruun, Adam Lesiak, Gary Wayman, Robert Bucelli and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of neurochemistry, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Essential Roles for ARID1B in Dendritic Arborization and Spine Morphology of Developing Pyramidal Neurons.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2016
    Article
  19. Molecular Mechanisms of Sympathetic Remodeling and Arrhythmias.Circulation. Arrhythmia and electrophysiology · 2016
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Woo-Yang KimDepartment of Pharmacology and Toxicology, SUNY, Buffalo, New York, USA.
Eugene A Gonsiorek
Chris Barnhart
Monika A Davare
Abby J Engebose
Holly Lauridsen
Donald Bruun
Adam Lesiak
Gary Wayman
Robert Bucelli
Dennis Higgins
Pamela J Lein
Oregon Health & Science University · USBuffalo State University · USUniversity at Buffalo, State University of New York · USWashington State University · US

Funding

Retrograde Dystrophic Influence of IFN-gamma on NeuronsR01NS046649 · NINDS · OREGON HEALTH & SCIENCE UNIVERSITY · PI LEIN, PAMELA J · 2003 to 2006
$1.0M
NINDS NIH HHS NS046649NINDS NIH HHS R01 NS046649
6 · The paper itself

Abstract

Clinical and experimental evidence suggest that statins decrease sympathetic activity, but whether peripheral mechanisms involving direct actions on post-ganglionic sympathetic neurons contribute to this effect is not known. Because tonic activity of these neurons is directly correlated with the size of their dendritic arbor, we tested the hypothesis that statins decrease dendritic arborization in sympathetic neurons. Oral administration of atorvastatin (20 mg/kg/day for 7 days) significantly reduced dendritic arborization in vivo in sympathetic ganglia of adult male rats. In cultured sympathetic neurons, statins caused dendrite retraction and reversibly blocked bone morphogenetic protein-induced dendritic growth without altering cell survival or axonal growth. Supplementation with mevalonate or isoprenoids, but not cholesterol, attenuated the inhibitory effects of statins on dendritic growth, whereas specific inhibition of isoprenoid synthesis mimicked these statin effects. Statins blocked RhoA translocation to the membrane, an event that requires isoprenylation, and constitutively active RhoA reversed statin effects on dendrites. These observations that statins decrease dendritic arborization in sympathetic neurons by blocking RhoA activation suggest a novel mechanism by which statins decrease sympathetic activity and protect against cardiovascular and cerebrovascular disease.

Indexed as

AnimalsBlood PressureBone Morphogenetic ProteinsCell DifferentiationCells, CulturedCell ShapeDendritesEnzyme ActivationGanglia, SympatheticHeart RateHydroxymethylglutaryl-CoA Reductase InhibitorsMaleMevalonic AcidPrenylationProtein TransportRatsBone Morphogenetic ProteinsHydroxymethylglutaryl-CoA Reductase InhibitorsMevalonic AcidrhoA GTP-Binding ProteinTerpenes

Identifiers

PMID19209406
PMCPMC4277848
OpenAlexW2032925485

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.